Results 151 to 160 of about 112,471 (313)

Nasal airway resistance in moderately severe allergic rhinitis and impact of Vitamin D deficiency

Diwash Sunar, Smile Kajal, Shuchita Singh Pachaury, Yashdeep Gupta, Alok Thakar, Kapil Sikka, Hitesh Verma   +6 more
openalex   +1 more source

The cost of rhinitis in the United States: a national insurance claims analysis

, 2020
Lauren T. Roland, Sarah K. Wise, Heqiong Wang, Patrick Zhang, C. Christina Mehta, Joshua M. Levy   +5 more
openalex   +2 more sources

Mite-proof impermeable covers do not improve signs and symptoms of allergic rhinitis [PDF]

, 2003
Felix Chua
openalex   +1 more source

Treatment Patterns and Healthcare Utilization on Pediatric Atopic Dermatitis With Allergic Comorbidities: A Japanese Claims‐Based Study

The Journal of Dermatology, EarlyView.
ABSTRACT Atopic dermatitis (AD) is a chronic, itchy skin disease that often begins in infancy and may persist into adulthood. The high co‐occurrence of allergic comorbidities (ACMs; asthma, food allergy, and allergic rhinitis) makes it a growing public health concern.
Masaki Futamura, Yumi Kang, Ambrish Singh, Junichi Danjo, Takashi Matsuo, Hitoe Torisu‐Itakura, Mizuho Nagao   +6 more
wiley   +1 more source

Clinical characteristics and biomarker screening for dry nose. [PDF]

Asia Pac Allergy
Meng Y, Wang Y, Yang J, Wang C, Zhang L.
europepmc   +1 more source

Long‐Term, Site‐Specific Effectiveness of Tralokinumab in Atopic Dermatitis: A 72‐Week Real‐World Study

The Journal of Dermatology, EarlyView.
ABSTRACT Tralokinumab, an anti‐IL‐13 antibody, is effective for atopic dermatitis (AD); however, its long‐term (> 1 year) effectiveness specific to each anatomical site is unknown in real‐world settings. To evaluate 72‐week effectiveness of tralokinumab on different anatomical sites in AD, we studied 208 patients with moderate‐to‐severe AD treated with
Mizuki Shiba, Teppei Hagino, Akihiko Uchiyama, Hidehisa Saeki, Eita Fujimoto, Sei‐ichiro Motegi, Naoko Kanda   +6 more
wiley   +1 more source

Cost-effectiveness of antihistaminics in adults' patients with allergic rhinitis. [PDF]

Cost Eff Resour Alloc
Buendía JA, Patino DG.
europepmc   +1 more source

Image 4_Expression and correlation of SOCS3 and Eotaxin mRNA and proteins levels in nasal mucosal tissue of allergic rhinitis patients.tif

Zhaopeng Kang (632466), Lian Xu (412491), Ping Ai (9912567), Wei Qu (268253), Tang Li (4542), Lixin Wang (343011)   +5 more
openalex   +1 more source

Deficiency of Vitamin D in Allergic Rhinitis: A Possible Factor in Multifactorial Disease

, 2014
Anil Jain, Pankaj R. Shah, Datt Modh, Bhaskar Thakkar, Ashish Katarkar, Krupal Joshi   +5 more
openalex   +1 more source

Bordetella BcrH1 and BcrH2 Are Specific Chaperones for the Pore‐Forming Complex

Microbiology and Immunology, EarlyView.
ABSTRACT Bordetella has a type III secretion system that secretes virulence proteins crucial to the establishment of infection. The genes encoding components of the Bordetella type III secretion system are located in the bsc region on the chromosome. This region includes the bcrH1 and bcrH2 genes, which respectively encode the proteins BcrH1 and BcrH2.
Yuya Kishino, Toshinobu Ogawa, Hiroko Sato, Akio Abe, Asaomi Kuwae   +4 more
wiley   +1 more source